Free Trial
NASDAQ:IRMD

iRadimed (IRMD) Stock Price, News & Analysis

iRadimed logo
$56.69 -0.76 (-1.32%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$56.52 -0.16 (-0.29%)
As of 07/18/2025 06:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About iRadimed Stock (NASDAQ:IRMD)

Key Stats

Today's Range
$56.37
$58.43
50-Day Range
$51.09
$61.83
52-Week Range
$42.34
$63.29
Volume
30,893 shs
Average Volume
44,061 shs
Market Capitalization
$720.81 million
P/E Ratio
36.57
Dividend Yield
1.20%
Price Target
$72.00
Consensus Rating
Buy

Company Overview

iRadimed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
91st Percentile Overall Score

IRMD MarketRank™: 

iRadimed scored higher than 91% of companies evaluated by MarketBeat, and ranked 28th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    iRadimed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    iRadimed has received no research coverage in the past 90 days.

  • Read more about iRadimed's stock forecast and price target.
  • Earnings Growth

    Earnings for iRadimed are expected to grow by 20.48% in the coming year, from $1.66 to $2.00 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of iRadimed is 36.57, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.50.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of iRadimed is 36.57, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.01.

  • Price to Book Value per Share Ratio

    iRadimed has a P/B Ratio of 8.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about iRadimed's valuation and earnings.
  • Percentage of Shares Shorted

    2.88% of the float of iRadimed has been sold short.
  • Short Interest Ratio / Days to Cover

    iRadimed has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in iRadimed has recently decreased by 3.02%, indicating that investor sentiment is improving.
  • Dividend Yield

    iRadimed pays a meaningful dividend of 1.18%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    iRadimed has only been increasing its dividend for 1 years.

  • Dividend Coverage

    The dividend payout ratio of iRadimed is 43.87%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, iRadimed will have a dividend payout ratio of 34.00% next year. This indicates that iRadimed will be able to sustain or increase its dividend.

  • Read more about iRadimed's dividend.
  • Percentage of Shares Shorted

    2.88% of the float of iRadimed has been sold short.
  • Short Interest Ratio / Days to Cover

    iRadimed has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in iRadimed has recently decreased by 3.02%, indicating that investor sentiment is improving.
    • Insider Buying vs. Insider Selling

      In the past three months, iRadimed insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      36.80% of the stock of iRadimed is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      92.34% of the stock of iRadimed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

    • Read more about iRadimed's insider trading history.
    Receive IRMD Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for iRadimed and its competitors with MarketBeat's FREE daily newsletter.

    IRMD Stock News Headlines

    Market Panic: Trump Just Dropped a Bomb on Your Stocks
    tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
    Iradimed Corp Bottom Line Rises In Q1
    Iradimed Announces Quarterly Results
    See More Headlines

    IRMD Stock Analysis - Frequently Asked Questions

    iRadimed's stock was trading at $55.00 at the beginning of 2025. Since then, IRMD shares have increased by 3.1% and is now trading at $56.69.

    iRadimed Corporation (NASDAQ:IRMD) issued its earnings results on Thursday, February, 13th. The medical equipment provider reported $0.40 earnings per share for the quarter, missing analysts' consensus estimates of $0.45 by $0.05. The medical equipment provider had revenue of $19.39 million for the quarter, compared to analyst estimates of $19.09 million. iRadimed had a trailing twelve-month return on equity of 23.28% and a net margin of 26.33%.
    Read the conference call transcript
    .

    Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that iRadimed investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Broadcom (AVGO) and Alphabet (GOOG).

    Company Calendar

    Last Earnings
    2/13/2025
    Record date for 5/30 Dividend
    5/20/2025
    Ex-Dividend for 5/30 Dividend
    5/20/2025
    Dividend Payable
    5/30/2025
    Today
    7/18/2025
    Next Earnings (Estimated)
    7/30/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED INSTRUMENTS
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:IRMD
    CIK
    1325618
    Employees
    110
    Year Founded
    N/A

    Price Target and Rating

    High Price Target
    $72.00
    Low Price Target
    $72.00
    Potential Upside/Downside
    +27.0%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    1 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    $1.55
    Trailing P/E Ratio
    36.57
    Forward P/E Ratio
    34.15
    P/E Growth
    N/A
    Net Income
    $19.23 million
    Net Margins
    26.33%
    Pretax Margin
    33.23%
    Return on Equity
    23.28%
    Return on Assets
    20.59%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    8.87
    Quick Ratio
    7.62

    Sales & Book Value

    Annual Sales
    $73.24 million
    Price / Sales
    9.85
    Cash Flow
    $1.56 per share
    Price / Cash Flow
    36.31
    Book Value
    $6.85 per share
    Price / Book
    8.28

    Miscellaneous

    Outstanding Shares
    12,720,000
    Free Float
    8,036,000
    Market Cap
    $721.10 million
    Optionable
    Optionable
    Beta
    0.91

    Social Links

    Beginner's Guide To Retirement Stocks Cover

    Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

    Get This Free Report

    This page (NASDAQ:IRMD) was last updated on 7/19/2025 by MarketBeat.com Staff
    From Our Partners